P-055: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE ERYTHROCYTE PYRUVATE KINASE ACTIVATOR ETAVOPIVAT IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE.

2022

https://researcherprofiles.org/profile/425025952

COATES T., LAL A., BROWN R., KALFA T., KWIATKOWSKI J., BREVARD J., TRENOR C., WOOD K., SHETH S.